Trial record 5 of 89 for: "Neuromuscular Disease" | "Norepinephrine"
Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01331109|
Recruitment Status : Terminated
First Posted : April 7, 2011
Results First Posted : September 30, 2013
Last Update Posted : September 30, 2013
Cypress Bioscience, Inc.
Information provided by (Responsible Party):
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
This study was terminated early, resulting in a small number of patients analyzed. Only descriptive statistics were presented.